✦ LIBER ✦

Renal function improves in liver transplant recipients when switched from a calcineurin inhibitor to sirolimus

✍ Scribed by Kyrsten D. Fairbanks; Joseph A. Eustace; Derek Fine; Paul J. Thuluvath

Book ID: 111723439
Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 87 KB
Volume: 9
Category: Article
ISSN: 1527-6465
DOI: 10.1053/jlts.2003.50183

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Renal function in renal or liver transpl

Renal function in renal or liver transplant recipients after conversion from a calcineurin inhibitor to sirolimus

✍ L. Bäckman; A. Varberg Reisæter; L. Wramner; B.-G. Ericzon; K. Salmela; C. Bratt 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

Calcineurin inhibitor minimization using

Calcineurin inhibitor minimization using sirolimus leads to improved renal function in pediatric heart transplant recipients

✍ Timothy J. Chinnock; Tamara Shankel; Douglas Deming; Drew Cutler; Shobha Sahney; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB

Improvement of renal function after the

Improvement of renal function after the switch from a calcineurin inhibitor to everolimus in liver transplant recipients with chronic renal dysfunction

✍ Javier F. Castroagudín; Esther Molina; Rafael Romero; Esteban Otero; Santiago To 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB 👁 1 views

Chronic renal dysfunction is a frequent and severe complication in solid-organ transplant recipients. Calcineurin inhibitors (CNIs) are the main pathogenic factors of renal dysfunction. Switching from CNIs to nonnephrotoxic drugs, such as mammalian target of rapamycin inhibitors (everolimus and siro

A randomized controlled trial of late co

A randomized controlled trial of late conversion from calcineurin inhibitor (CNI)-based to sirolimus-based immunosuppression in liver transplant recipients with impaired renal function

✍ Christopher J.E. Watson; Alexander E.S. Gimson; Graeme J. Alexander; Michael E.D 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 307 KB 👁 1 views

Renal impairment is common in patients after liver transplantation and is attributable in large part to the use of calcineurin inhibitor (CNI)-based immunosuppression. We sought to determine whether conversion to sirolimus-based immunosuppression was associated with improved renal function. In a sin

Sirolimus in liver transplant recipients

Sirolimus in liver transplant recipients with renal dysfunction offers no advantage over low-dose calcineurin inhibitor regimens

✍ Derek DuBay; Rob J. Smith; Kenneth G. Qiu; Gary A. Levy; Leslie Lilly; George Th 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB

The purpose of this study is to review the clinical experience with sirolimus immunosuppression in liver transplant patients with calcineurin inhibitor-induced chronic renal insufficiency. The study design is a case-control retrospective series. Fifty-seven liver transplant patients with renal insuf

The effect of switching from calcineurin

The effect of switching from calcineurin inhibitor to sirolimus on the incidence of skin cancers in kidney transplant recipients

✍ RF McQuillan; CM O'Seaghdha; A Bagatto; M Manusamy; N Errakiah; C Sinnott; P O’K 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB